Frederick R. Vogel

1.7k total citations
29 papers, 1.4k citations indexed

About

Frederick R. Vogel is a scholar working on Epidemiology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Frederick R. Vogel has authored 29 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 14 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Frederick R. Vogel's work include Influenza Virus Research Studies (9 papers), Immunotherapy and Immune Responses (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Frederick R. Vogel is often cited by papers focused on Influenza Virus Research Studies (9 papers), Immunotherapy and Immune Responses (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Frederick R. Vogel collaborates with scholars based in United States, France and Norway. Frederick R. Vogel's co-authors include L Chedid, Michael F. Powell, H. Shaw Warren, Nava Sarver, Catherine Caillet, Inca Kusters, Jean Haensler, Claude Leclerc, M.P. Schutze and Patricia Caspar and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Annual Review of Immunology.

In The Last Decade

Frederick R. Vogel

28 papers receiving 1.3k citations

Peers

Countries citing papers authored by Frederick R. Vogel

Since Specialization

Citations

This map shows the geographic impact of Frederick R. Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick R. Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick R. Vogel more than expected).

Fields of papers citing papers by Frederick R. Vogel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick R. Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick R. Vogel. The network helps show where Frederick R. Vogel may publish in the future.

Co-authorship network of co-authors of Frederick R. Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick R. Vogel. A scholar is included among the top collaborators of Frederick R. Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick R. Vogel. Frederick R. Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Role of Adjuvants in HIV Vaccine Design 2015 ·Antibiotics and chemotherapy/Antibiotica et chemotherapia ·Frederick R. Vogel	0
2	Intanza® 15mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses 2012 ·Vaccine ·Filippo Ansaldi, Paola Canepa, Antonella Ceravolo, (unknown), Daniela de Florentiis, Raymond P. Oomen, Frederick R. Vogel, Martine Denis, Sandrine Samson, Giancarlo Icardi	21
3	AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice 2010 ·Vaccine ·Catherine Caillet, (unknown), (unknown), (unknown), Florence Boudet, Frederick R. Vogel, Agnès Hoffenbach, (unknown), Inca Kusters	30
4	A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models 2009 ·Influenza and Other Respiratory Viruses ·Rebecca Jane Cox, Diane Major, (unknown), Abdullah S. Madhun, Karl A. Brokstad, (unknown), Jon Smith, Frederick R. Vogel, Maria Zambon, Lars R. Haaheim, John Wood	29
5	Heterosubtype Neutralizing Responses to Influenza A (H5N1) Viruses Are Mediated by Antibodies to Virus Haemagglutinin 2009 ·PLoS ONE ·Jean‐Michel Garcia, Stéphanie Pépin, Nadège Lagarde, S. K. Edward, Frederick R. Vogel, Kwok Hung Chan, Susan S. Chiu, Malik Peiris	36
6	A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine 2009 ·Vaccine ·Rebecca Jane Cox, Abdullah S. Madhun, (unknown), Haakon Sjursen, Diane Major, (unknown), Katja Höschler, Mélanie Saville, Frederick R. Vogel, William Barclay, Isabella Donatelli, Maria Zambon, John Wood, Lars R. Haaheim	122
7	Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase 2009 ·Vaccine ·(unknown), Catherine Caillet, Hongxing Hu, Fan Zhou, Heng Ding, Guoliang Zhang, Boping Zhou, Shixia Wang, Shan Lu, Philippe Buchy, Vincent Deubel, Frederick R. Vogel, Paul Zhou	46
8	Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells 2007 ·Influenza and Other Respiratory Viruses ·(unknown), Adolfo Garcı́a-Sastre, Peter Palese, Terrence M. Tumpey, Taronna R. Maines, Jacqueline M. Katz, Frederick R. Vogel, (unknown)	9
9	Improving Vaccine Performance with Adjuvants 2000 ·Clinical Infectious Diseases ·Frederick R. Vogel	158
10	Adjuvants in perspective. 1998 ·PubMed ·Frederick R. Vogel	46
11	Workshop on the control and standardization of nucleic acid vaccines 1997 ·Vaccine ·(unknown), Karen L. Goldenthal, Frederick R. Vogel, Regina Rabinovich, Teresa Marqués Aguado	2
12	Adsorption to aluminum hydroxide promotes the activity of IL-12 as an adjuvant for antibody as well as type 1 cytokine responses to HIV-1 gp120 1997 ·The Journal of Immunology ·Dragana Janković, Patricia Caspar, M Zweig, (unknown), S D Showalter, Frederick R. Vogel, Ali Sher	87
13	Discussion 1997 ·Vaccine ·Teresa Marqués Aguado, (unknown), Regina Rabinovich, H. J. Smith, Frederick R. Vogel	1
14	A Compendium of Vaccine Adjuvants and Excipients 1995 ·Pharmaceutical biotechnology ·Frederick R. Vogel, Michael F. Powell	175
15	Immunologic Adjuvants for Modern Vaccine Formulations 1995 ·Annals of the New York Academy of Sciences ·Frederick R. Vogel	38
16	The role of adjuvants in retroviral vaccines 1995 ·International Journal of Immunopharmacology ·Frederick R. Vogel	20
17	Suppression of in vitro lymphocyte function by cks 17 a synthetic retroviral envelope peptide modulation of suppression by muramyl dipeptide mdp 1989 ·The FASEB Journal ·Frederick R. Vogel, F Audibert, L Chedid	1
18	Cryptococcal capsular polysaccharide-induced modulation of murine immune responses 1982 ·Infection and Immunity ·(unknown), (unknown), Frederick R. Vogel, Harvey M. Friedman	39
19	Detection of antibodies to Legionella pneumophila in immune guinea pig serum by solid-phase immunofluorescence 1981 ·Journal of Clinical Microbiology ·Frederick R. Vogel, Thomas Klein, Steven Specter, Matt D. T. Hitchings, (unknown)	8
20	Detection of IgG Antibodies against Pigeon Intestinal Mucosa Antigens in Pigeon Breeders’ Sera using the Immunofluorescent Technique 1976 ·International Archives of Allergy and Immunology ·J. Sennekamp, Frederick R. Vogel, (unknown)	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact